[go: up one dir, main page]

ES8800926A1 - Procedimiento para la obtencion de compuestos carbonilicos - Google Patents

Procedimiento para la obtencion de compuestos carbonilicos

Info

Publication number
ES8800926A1
ES8800926A1 ES554488A ES554488A ES8800926A1 ES 8800926 A1 ES8800926 A1 ES 8800926A1 ES 554488 A ES554488 A ES 554488A ES 554488 A ES554488 A ES 554488A ES 8800926 A1 ES8800926 A1 ES 8800926A1
Authority
ES
Spain
Prior art keywords
general formula
procedure
obtaining
compounds
carbonilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES554488A
Other languages
English (en)
Other versions
ES554488A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES554488A0 publication Critical patent/ES554488A0/es
Publication of ES8800926A1 publication Critical patent/ES8800926A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE COMPUESTOS CARBONILICOS, DE FORMULA GENERAL (I), Y DE SUS SALES FARMACEUTICAMENTE ACEPTABLES. CONSISTE EN TRANSFORMAR EN UN COMPUESTO DE FORMULA GENERAL (II), UNO DE LOS RESTOS ACO O ACO1 EN UN GRUPO -COOR1 O EN UN RESTO DE FORMULA GENERAL (III), REALIZANDOSE DICHA TRANSFORMACION BAJO CONDICIONES HIDROLITICAS, POR EJEMPLO, MEDIANTE ACIDOS MINERALES QUE CONTENGAN AGUA, Y VENTAJOSAMENTE EN PRESENCIA DE UN CATALIZADOR ACIDO Y DE AGENTES DE CONDENSACION ACEPTORES DE AGUA O EN PRESENCIA DE MEDIOS LIGADORES DE ACIDO. DE APLICACION EN LA PREPARACION DE PREPARADOS FARMACEUTICOS UTILIZADOS EN EL TRATAMIENTO PROFILACTICO Y TERAPEUTICO DEL CUERPO HUMANO Y ANIMAL.
ES554488A 1984-09-14 1986-04-29 Procedimiento para la obtencion de compuestos carbonilicos Expired ES8800926A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH438884 1984-09-14

Publications (2)

Publication Number Publication Date
ES554488A0 ES554488A0 (es) 1987-12-01
ES8800926A1 true ES8800926A1 (es) 1987-12-01

Family

ID=4275188

Family Applications (4)

Application Number Title Priority Date Filing Date
ES546946A Expired ES8802025A1 (es) 1984-09-14 1985-09-13 Procedimiento para la obtencion de compuestos de fenilalqui-lo
ES546945A Expired ES8701158A1 (es) 1984-09-14 1985-09-13 Procedimiento para la obtencion de compuestos carbonilicos
ES554488A Expired ES8800926A1 (es) 1984-09-14 1986-04-29 Procedimiento para la obtencion de compuestos carbonilicos
ES554487A Expired ES8706669A1 (es) 1984-09-14 1986-04-29 Procedimiento para la obtencion de compuestos carbonilicos

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES546946A Expired ES8802025A1 (es) 1984-09-14 1985-09-13 Procedimiento para la obtencion de compuestos de fenilalqui-lo
ES546945A Expired ES8701158A1 (es) 1984-09-14 1985-09-13 Procedimiento para la obtencion de compuestos carbonilicos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES554487A Expired ES8706669A1 (es) 1984-09-14 1986-04-29 Procedimiento para la obtencion de compuestos carbonilicos

Country Status (16)

Country Link
US (1) US4853393A (es)
EP (2) EP0174653A3 (es)
JP (2) JPS6172752A (es)
KR (1) KR890000225B1 (es)
AU (1) AU4744985A (es)
DD (1) DD237165A5 (es)
DK (2) DK416885A (es)
ES (4) ES8802025A1 (es)
FI (2) FI853478L (es)
GR (2) GR852215B (es)
HU (1) HU194871B (es)
IL (1) IL76366A (es)
NO (1) NO853609L (es)
NZ (1) NZ213461A (es)
PT (2) PT81116B (es)
ZA (1) ZA857034B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK159420C (da) * 1983-03-09 1991-03-11 Ciba Geigy Ag N-(piperidinyl-alkyl)-carboxamider og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelsen af forbindelserne til fremstilling af antipsykotiske farmaceutiske praeparater
IL76366A (en) * 1984-09-14 1989-07-31 Ciba Geigy Ag 2,6-dialkyl-4-aryl-3,5-diacyl-1,4-dihydropyridine derivatives,processes for their manufacture and pharmaceutical preparations containing them
JPS61227567A (ja) * 1985-04-01 1986-10-09 Eisai Co Ltd １，４−ジヒドロピリジン誘導体
EP0216542B1 (en) * 1985-09-13 1991-12-11 The Green Cross Corporation Dihydropyridine derivatives
EP0222702A3 (de) * 1985-11-06 1988-01-07 Ciba-Geigy Ag Basische Carbonylverbindungen
DE3601397A1 (de) * 1986-01-18 1987-07-23 Bayer Ag Substituierte 1,4-dihydropyridin-3-carbonsaeurepiperazide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
WO1988007531A1 (fr) * 1987-03-27 1988-10-06 Byk Gulden Lomberg Chemische Fabrik Gmbh Nouveaux composes optiquement actifs
ES2059416T3 (es) * 1987-03-27 1994-11-16 Byk Gulden Lomberg Chem Fab 1,4-dihidropiridina-enantiomeros.
DE3724909A1 (de) * 1987-07-28 1989-02-09 Bayer Ag Neue substituierte nitro-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung
US5258519A (en) * 1990-11-13 1993-11-02 Glaxo Inc. Dihydropyridine vasodilators agents
US5100892A (en) * 1990-11-13 1992-03-31 Glaxo Inc. Dihydropyridine vasodilator agents
US6211198B1 (en) 1993-04-05 2001-04-03 Synaptic Pharmaceutical Corporation Dihydropyridines and new uses thereof
US5767131A (en) * 1993-04-05 1998-06-16 Synaptic Pharmaceutical Corporation Dihydropyridines and new uses thereof
PL350904A1 (en) 1999-03-26 2003-02-10 Astrazeneca Ab Novel compounds
NZ521853A (en) * 2000-04-11 2003-11-28 Sankyo Co Stabilized pharmaceutical compositions containing a calcium blocker
GB0013060D0 (en) * 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
GB0021670D0 (en) * 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
GB0117899D0 (en) * 2001-07-23 2001-09-12 Astrazeneca Ab Chemical compounds
SE0102809D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab Novel compounds
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284634A (en) * 1975-07-02 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, and pharmaceutical method of the same
JPS5283672A (en) * 1976-01-01 1977-07-12 Yamanouchi Pharmaceut Co Ltd Novel 2-amino-1,4-dihydropyridine derivatives
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
WO1983003249A1 (fr) * 1982-03-17 1983-09-29 Yoshitomi Pharmaceutical Derives de 1,4-dihydropyridine-3,5-dicarboxylate
EP0094159B1 (en) * 1982-05-10 1990-03-14 Takeda Chemical Industries, Ltd. Dihydropyridine derivatives, their production and use
WO1984002702A1 (fr) * 1983-01-11 1984-07-19 Takeda Chemical Industries Ltd Derives de dihydropyridine
WO1983004023A1 (en) * 1982-05-10 1983-11-24 Takeda Chemical Industries, Ltd. Dihydropyridine derivatives
JPS58201765A (ja) * 1982-05-10 1983-11-24 Takeda Chem Ind Ltd ジヒドロピリジン誘導体，その製造法および用途
IT1198377B (it) * 1982-06-03 1988-12-21 Pierrel Spa Esteri basici ad attivita' calcioanatagonista,procedimenti per la loro preparazione e relative composizioni farmaceutiche
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
EP0111455A3 (de) * 1982-12-10 1984-07-25 Ciba-Geigy Ag Ungesättigte Lactone
US4603135A (en) * 1983-10-17 1986-07-29 Takeda Chemical Industries, Ltd. Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates
IL76366A (en) * 1984-09-14 1989-07-31 Ciba Geigy Ag 2,6-dialkyl-4-aryl-3,5-diacyl-1,4-dihydropyridine derivatives,processes for their manufacture and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
ES546945A0 (es) 1986-11-16
EP0174653A3 (de) 1987-06-16
PT81117B (en) 1987-07-15
DK416985D0 (da) 1985-09-13
EP0174654A3 (de) 1987-07-22
ES554488A0 (es) 1987-12-01
PT81116A (en) 1985-10-01
ES554487A0 (es) 1987-07-01
US4853393A (en) 1989-08-01
AU4744985A (en) 1986-03-20
ES8701158A1 (es) 1986-11-16
HUT38339A (en) 1986-05-28
KR890000225B1 (ko) 1989-03-11
DK416985A (da) 1986-03-15
GR852216B (es) 1986-01-14
FI853477A7 (fi) 1986-03-15
PT81117A (en) 1985-10-01
EP0174654A2 (de) 1986-03-19
HU194871B (en) 1988-03-28
PT81116B (en) 1987-07-15
FI853478A7 (fi) 1986-03-15
ES8706669A1 (es) 1987-07-01
NZ213461A (en) 1989-07-27
FI853477L (fi) 1986-03-15
JPS6172751A (ja) 1986-04-14
FI853477A0 (fi) 1985-09-11
FI853478A0 (fi) 1985-09-11
IL76366A (en) 1989-07-31
JPS6172752A (ja) 1986-04-14
ES8802025A1 (es) 1987-02-16
EP0174653A2 (de) 1986-03-19
NO853609L (no) 1986-03-17
IL76366A0 (en) 1986-01-31
FI853478L (fi) 1986-03-15
ES546946A0 (es) 1987-02-16
GR852215B (es) 1986-01-14
DK416885A (da) 1986-03-15
DK416885D0 (da) 1985-09-13
DD237165A5 (de) 1986-07-02
KR860002496A (ko) 1986-04-26
ZA857034B (en) 1987-05-27

Similar Documents

Publication Publication Date Title
ES8800926A1 (es) Procedimiento para la obtencion de compuestos carbonilicos
CU22305A3 (es) Procedimiento para la preparacion de un derivado de aminoacidos
ES2053524T3 (es) Un procedimiento para preparar un compuesto quimico.
IS3156A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
ES2020974B3 (es) Medicamente conteniendo dipiridamol o mopidamol y o-acido acetilsalicilico o sus sales tratables fisiologicamente, procedimiento para su fabricacion y su utilizacion para combatir la formacion de trombos
FR2541115B1 (fr) Medicament renfermant un peptide en tant que principe actif pour le traitement des affections ulcereuses
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
SE8002322L (sv) Medel for behandling av inflammatoriska tarmsjukdomar
IE830607L (en) Imidazolylphenylpyridazinones
DK197286D0 (da) Terapeutiske praeparater til detektering og/eller behandling af pattedyrtumorer
PH15895A (en) Oxiranebutanoic acid derivatives its pharmaceutical composition and use
ES8603499A1 (es) Procedimiento para la obtencion de azoles 2,4,5-trisustituidos.
IL83775A0 (en) Fumaramide derivatives and pharmaceutical compositions containing them for treating skin diseases
ES8706692A1 (es) Un metodo para preparar nuevos derivados de cefem
DK421586A (da) Irreversible dopamin-beta-hydroxylaseinhibitorer
NO883074L (no) Fremgangsmaate til fremstilling av 3-desmetyl-4-fluor-mevalonsyrederivater.
ES2010439A6 (es) Procedimiento para la preparacion de nuevas sales antivirales y estimuladoras del sistema inmunologico.
DK418986D0 (da) Pyrrolobenzimidazoler, pyrrolobenzoxazoler og pyrrolobenzthiazoler, fremgangsmaader til fremstilling heraf og laegemidler med indhold heraf
ES2053430T3 (es) Procedimiento para la obtencion de derivados de aminoacidos.
DK552985A (da) Mercaptanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK89286A (da) Renininhiberende peptid-aminoalkoholderivater, som ogsaa inhiberer sure proteaser, fremgangsmaade til fremstilling deraf og derivaternes terapeutiske anvendelse
ES2084585T3 (es) Derivados de la 6-oxo-piridazina, procedimiento para su obtencion y medicamentos que contienen estos compuestos.
SE8501518L (sv) Farmaceutiska preparat
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
ES2067450T3 (es) Procedimiento para la preparacion de aciloxialcanosulfonatos.